Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from <i>Californiconus californicus</i>, for Treating Type 2 Diabetes
The FDA’s approval of peptide drugs such as Ziconotide or Exendin for pain relief and diabetes treatment, respectively, enhanced the interest to explore novel conotoxins from <i>Conus</i> species venom. In general, conotoxins can be used in pathologies where voltage-gated channels, membr...
المؤلفون الرئيسيون: | Pavel H. Lugo-Fabres, Leslie M. Otero-Sastre, Johanna Bernáldez-Sarabia, Tanya A. Camacho-Villegas, Noemi Sánchez-Campos, Janeth Serrano-Bello, Luis A. Medina, Saé Muñiz-Hernández, Lizbeth de la Cruz, Isabel Arenas, Antonio Barajas-Martínez, David E. Garcia, Linda Nuñez-Garcia, Jorge González-Canudas, Alexei F. Licea-Navarro |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
MDPI AG
2021-08-01
|
سلاسل: | Biomedicines |
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.mdpi.com/2227-9059/9/8/936 |
مواد مشابهة
-
Systemic antihyperalgesic effect of a novel conotoxin from Californiconus californicus in an inflammatory pain model
حسب: Joaquín López-Carrillo, وآخرون
منشور في: (2025-01-01) -
The Diversified O-Superfamily in <i>Californiconus californicus</i> Presents a Conotoxin with Antimycobacterial Activity
حسب: Johanna Bernáldez-Sarabia, وآخرون
منشور في: (2019-02-01) -
Chimeric Peptides from <i>Californiconus californicus</i> and <i>Heterodontus francisci</i> with Antigen-Binding Capacity: A Conotoxin Scaffold to Create Non-Natural Antibodies (NoNaBodies)
حسب: Salvador Dueñas, وآخرون
منشور في: (2023-04-01) -
Conotoxin Patenting Trends in Academia and Industry
حسب: Noemi Sanchez-Campos, وآخرون
منشور في: (2022-08-01) -
Determination of the Resistance Levels, Synergists and Detoxification Enzymes of the Predatory Mite Neoseiulus californicus (McGregor) (Acari: Phytoseiidae) Populations to Milbemectin
حسب: Fatma Aydınlı, وآخرون
منشور في: (2013-09-01)